CETP and Hepatic steatosis: Liver macrophages largely contribute to hepatic CETP expression, and attenuation of hepatic steatosis, accompanied by attenuation of liver inflammation, as reflected by reduced macrophage content, by the anti-dyslipidemic drug niacin decreased hepatic CETP expression and the plasma CETP level [22].